Andrew Kambugu

Andrew Kambugu
Born
Andrew Ddungu Kambugu

(1973-02-22) February 22, 1973[1]
Uganda
Alma materMakerere University
(Bachelor of Medicine and Surgery),
(Master of Medicine),
Royal College of Physicians
(Post Doctoral Fellowship)
OccupationsPhysician, researcher, and academic
Years active1998–present
TitleThe Sande-McKinnell Executive Director at Infectious Disease Institute
SpouseJoyce Balagadde-Kambugu

Andrew Ddungu Kambugu is a Ugandan physician who serves as the Sande-McKinnell Executive Director at the Infectious Disease Institute in Uganda[2] and an honorary senior lecturer at Makerere University College of Health Sciences.[3] He is also an adjunct associate professor at the University of Minnesota.[4][3] In July 2020, he was appointed to the United Nations 2021 Food System Scientific Group.[5][6]

Early life and education

Kambugu was born on 22 February 1973 in Kampala, Uganda. He attended Buganda Road Primary School and went on to King's College Budo for both his O and A levels. He studied medicine at Makerere University between 1992 and 2002, graduating with a master's degree in medicine. He then completed a fellowship in infectious diseases at the University of Utah and the University of Manitoba from 2002 to 2005, as well as a fellowship at the Royal College of Physicians in 2014.[1]

Career

Kambugu trained at Mulago National Hospital and Makerere University Medical School in Kampala.[1] He also served as a Medical Officer of Uganda Telecom from 1998 to 1999.[1] He served as the Head of Preventative Care and Treatment Programme at the Infectious Disease Institute (IDI) from 2005 to 2012. At the IDI, he became Head of Research Programme in 2012 and the Sande-McKinnell Executive Director in 2018, continuing to serve in both roles as of 2026.[1][7] Academically, Kambugu is an honorary senior lecturer in the Department of Medicine at Makerere University College of Health Sciences, as well as an adjuct associate professor for infectious diseases at the University of Minnesota.[1][3] Kambugu serves as a consultant to the World Health Organization on antiretroviral therapy since 2010.[8]

Research

As of 2026, Kambugu has an h-index of 55 and has been cited more than ten thousand times.[9] He is a member of the council of the African Centers of Excellence in Bioinformatics and Data Intensive Sciences.[10] His most influential work includes studies on managing treatment of antiretroviral therapy with cryptococcal meningitis,[11][12][13] studies of antiretroviral medications for HIV,[14][15] work on patient retention in HIV care,[16][17] and complications of HIV infection.[18][19]

Personal life

Kambugu is married to Joyce Balagadde-Kambugu and they have two children.[1][20]

References

  1. 1 2 3 4 5 6 7 "Curriculum Vitae: Dr. Andrew D Kambugu" (PDF). Archived (PDF) from the original on 28 May 2026. Retrieved 28 May 2026.
  2. ↑ "Dr. Andrew D Kambugu". Infectious Diseases Institute. Retrieved 19 December 2020.
  3. 1 2 3 "Dr. Andrew D Kambugu, M.Med, FRCP (London)". Health Informatics Research Group. December 7, 2017.
  4. ↑ "PROFILE: Makerere University's Prof. Waiswa appointed on WHO advisory board - Education News Uganda". Archived from the original on 2020-05-17. Retrieved 2020-12-18.
  5. ↑ "Advisory Committee and Scientific Group for the 2021 Food Systems Summit". United Nations Secretary-General. June 29, 2020.
  6. ↑ "The Executive Director, Dr Andrew Kambugu named on the UN 2021 Food Systems Summit - INFECTIOUS DISEASES INSTITUTE". August 3, 2020.
  7. ↑ "Andrew Kambugu – Researchers for Global Health".
  8. ↑ Wamai, Mark (July 1, 2020). "IDI's Dr. Kambugu Named on UN 2021 Food Systems Summit Scientific Group". Makerere University News.
  9. ↑ "Andrew Kambugu". Google Scholar. Retrieved 2026-05-28.
  10. ↑ "About ACE Global". African Centers of Excellence in Bioinformatics & Data-Intensive Science. Retrieved 28 May 2026.
  11. ↑ Boulware, David R.; Meya, David B.; Muzoora, Conrad; Rolfes, Melissa A.; Huppler Hullsiek, Katherine; Musubire, Abdu; Taseera, Kabanda; Nabeta, Henry W.; Schutz, Charlotte; Williams, Darlisha A.; Rajasingham, Radha (2014-06-26). "Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis". New England Journal of Medicine. 370 (26): 2487–2498. doi:10.1056/NEJMoa1312884. ISSN 0028-4793. PMC 4127879. PMID 24963568.
  12. ↑ Kambugu, Andrew; Meya, David B; Rhein, Joshua; O'Brien, Meagan; Janoff, Edward N; Ronald, Allan R; Kamya, Moses R; Mayanja-Kizza, Harriet; Sande, Merle A; Bohjanen, Paul R; Boulware, David R (2008-06-01). "Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy". Clinical Infectious Diseases. 46 (11): 1694–1701. doi:10.1086/587667. ISSN 1537-6591. PMC 2593910. PMID 18433339.
  13. ↑ Boulware, David R.; Meya, David B.; Bergemann, Tracy L.; Wiesner, Darin L.; Rhein, Joshua; Musubire, Abdu; Lee, Sarah J.; Kambugu, Andrew; Janoff, Edward N.; Bohjanen, Paul R. (2010-12-21). "Clinical Features and Serum Biomarkers in HIV Immune Reconstitution Inflammatory Syndrome after Cryptococcal Meningitis: A Prospective Cohort Study". PLOS Medicine. 7 (12) e1000384. doi:10.1371/journal.pmed.1000384. ISSN 1549-1676. PMC 3014618. PMID 21253011.
  14. ↑ Paton, Nicholas I.; Musaazi, Joseph; Kityo, Cissy; Walimbwa, Stephen; Hoppe, Anne; Balyegisawa, Apolo; Kaimal, Arvind; Mirembe, Grace; Tukamushabe, Phionah; Ategeka, Gilbert; Hakim, James; Mugerwa, Henry; Siika, Abraham; Asienzo, Jesca; Castelnuovo, Barbara (2021-07-22). "Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV". New England Journal of Medicine. 385 (4): 330–341. doi:10.1056/NEJMoa2101609. ISSN 0028-4793.
  15. ↑ Paton, Nicholas I.; Kityo, Cissy; Hoppe, Anne; Reid, Andrew; Kambugu, Andrew; Lugemwa, Abbas; van Oosterhout, Joep J.; Kiconco, Mary; Siika, Abraham; Mwebaze, Raymond; Abwola, Mary (2014-07-17). "Assessment of Second-Line Antiretroviral Regimens for HIV Therapy in Africa". New England Journal of Medicine. 371 (3): 234–247. doi:10.1056/NEJMoa1311274. ISSN 0028-4793. PMID 25014688. S2CID 2031064.
  16. ↑ Geng, Elvin H.; Nash, Denis; Kambugu, Andrew; Zhang, Yao; Braitstein, Paula; Christopoulos, Katerina A.; Muyindike, Winnie; Bwana, Mwebesa Bosco; Yiannoutsos, Constantin T.; Petersen, Maya L.; Martin, Jeffrey N. (November 2010). "Retention in Care among HIV-Infected Patients in Resource-Limited Settings: Emerging Insights and New Directions". Current HIV/AIDS Reports. 7 (4): 234–244. doi:10.1007/s11904-010-0061-5. ISSN 1548-3568. PMC 3021803. PMID 20820972.
  17. ↑ Geng, Elvin H.; Odeny, Thomas A.; Lyamuya, Rita; Nakiwogga-Muwanga, Alice; Diero, Lameck; Bwana, Mwebesa; Braitstein, Paula; Somi, Geoffrey; Kambugu, Andrew; Bukusi, Elizabeth; Wenger, Megan; Neilands, Torsten B.; Glidden, David V.; Wools-Kaloustian, Kara; Yiannoutsos, Constantin (2016-04-01). "Retention in Care and Patient-Reported Reasons for Undocumented Transfer or Stopping Care Among HIV-Infected Patients on Antiretroviral Therapy in Eastern Africa: Application of a Sampling-Based Approach". Clinical Infectious Diseases. 62 (7): 935–944. doi:10.1093/cid/civ1004. ISSN 1058-4838. PMC 4787603. PMID 26679625.
  18. ↑ Kamya, Moses R; Mayanja-Kizza, Harriet; Kambugu, Andrew; Bakeera-Kitaka, Sabrina; Semitala, Fred; Mwebaze-Songa, Patricia; Castelnuovo, Barbara; Schaefer, Petra; Spacek, Lisa A; Gasasira, Anne F; Katabira, Elly; Colebunders, Robert; Quinn, Thomas C; Ronald, Allan; Thomas, David L (2007-10-01). "Predictors of Long-Term Viral Failure Among Ugandan Children and Adults Treated With Antiretroviral Therapy". JAIDS Journal of Acquired Immune Deficiency Syndromes. 46 (2): 187–193. doi:10.1097/QAI.0b013e31814278c0. ISSN 1525-4135.
  19. ↑ Reid, Andrew; Stöhr, Wolfgang; Walker, A. Sarah; Williams, Ian G.; Kityo, Cissy; Hughes, Peter; Kambugu, Andrew; Gilks, Charles F.; Mugyenyi, Peter; Munderi, Paula; Hakim, James; Gibb, Diana M.; Development of Antiretroviral Therapy Trial (2008-04-15). "Severe Renal Dysfunction and Risk Factors Associated with Renal Impairment in HIV‐Infected Adults in Africa Initiating Antiretroviral Therapy". Clinical Infectious Diseases. 46 (8): 1271–1281. doi:10.1086/533468. ISSN 1058-4838.
  20. ↑ "Dr. Andrew Kambugu - INFECTIOUS DISEASES INSTITUTE". July 17, 2018.
This page is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.